Welcome to our dedicated page for TERRASCENT news (Ticker: TSNDF), a resource for investors and traders seeking the latest updates and insights on TERRASCENT stock.
TerrAscend Corp (TSNDF) is a leading cannabis company with vertically integrated operations in Pennsylvania, New Jersey, Maryland, Michigan, and California. The company operates retail locations like The Apothecarium and Gage, with cultivation and manufacturing facilities. TerrAscend offers high-quality cannabis products, serving both medical and adult-use markets. With a diverse portfolio of brands like Cookies, Wana, and Valhalla Confections, TerrAscend is a prominent player in the North American cannabis sector.
TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, has announced it will host a conference call to discuss its third quarter 2024 results on Wednesday, November 6, 2024, at 5:00 p.m. Eastern Time. The company will release its financial results for the quarter ended September 30, 2024, after market close on the same day.
Conference call details include:
- Webcast: https://app.webinar.net/9j6aMNoEX1d
- Dial-in Number: 1-888-510-2154
- Replay: 1-289-819-1450 or 1-888-660-6345 (available until November 20, 2024, midnight ET)
- Replay Entry Code: 37705#
TerrAscend Corp. (TSX: TSND, OTCQX: TSNDF), a leading North American cannabis company, has announced the completion of the second draw of US$26 million in gross proceeds from its senior secured term loan. This brings the total gross proceeds to US$140 million from funds managed by FocusGrowth Asset Management, LP and other loan syndicate members.
The loan carries an interest rate of 12.75%, matures in August 2028, and contains no prepayment penalties. It is guaranteed by TerrAscend and TerrAscend USA, Inc., and secured by consolidated entities in Pennsylvania, California, Michigan, and certain entities in Maryland. The proceeds from the second draw were used to pay down the company's higher interest Michigan debt.
The initial draw of US$114 million was completed in August 2024. Notably, no warrants were issued as part of the loan. Ventum Capital Markets acted as the exclusive financial advisor for this transaction.
TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, has announced its participation in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18, 2024, in New York City. Key highlights include:
- Jason Wild, Executive Chairman, will join a panel discussion on cannabis reform's impact on valuations and investor engagement
- The panel is scheduled for September 18th at 8:00 AM ET
- Management team, including Wild, CEO Ziad Ghanem, and CFO Keith Stauffer, will host one-on-one meetings during the conference
This event provides an opportunity for TerrAscend to engage with institutional investors and discuss the evolving cannabis industry landscape.
TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, has announced a $10 million share repurchase program. The company's Board of Directors has authorized a normal course issuer bid (NCIB) to repurchase up to 10 million common shares over a 12-month period, representing 5% of the public float. The program will run from August 22, 2024, to August 21, 2025.
Executive Chairman Jason Wild expressed confidence in TerrAscend's future and commitment to enhancing shareholder value. The company is not obligated to purchase any shares and may suspend or terminate the program at any time. TerrAscend does not expect to incur debt to fund the repurchase program. Shares may be purchased on the Toronto Stock Exchange, OTCQX Best Market, or alternative trading systems, subject to a daily repurchase restriction of 65,361 shares.
TerrAscend Corp. (TSX: TSND, OTCQX: TSNDF) reported its Q2 2024 financial results, showing strong growth and improved profitability. Key highlights include:
- Net Revenue of $77.5 million, up 7.5% year-over-year
- Gross Profit Margin of 48.6%
- Adjusted EBITDA from continuing operations of $15.6 million, a 21.9% increase year-over-year
- Free Cash Flow of $11.7 million
- Maintained #1 market share position in New Jersey throughout H1 2024
The company achieved its 8th consecutive quarter of positive cash flow from continuing operations. TerrAscend also closed a $140 million senior secured term loan, providing financial flexibility for future growth and expansion strategies.
TerrAscend Corp. (TSX: TSND, OTCQX: TSNDF) has secured a $140 million senior secured term loan from FocusGrowth Asset Management and other syndicate members. The non-dilutive financing features a 12.75% interest rate and matures in August 2028 with no prepayment penalties. The loan includes an initial draw of $114 million for operations in Pennsylvania, Maryland, and California, with a second draw of $26 million expected in September 2024 for Michigan operations.
The proceeds will be used to retire existing debt and potentially fund M&A activities for geographic expansion. This financing strengthens TerrAscend's balance sheet and provides financial flexibility for growth, with no other material debt maturing until late 2027. The transaction also involved a related party participation from Jason Wild, an insider of the company, who invested approximately $7.5 million in the loan syndicate.
TerrAscend, a leading North American cannabis company, will host a conference call to discuss its second quarter 2024 financial results on August 8, 2024, at 5:00 p.m. Eastern Time. The results for the quarter ended June 30, 2024, will be released the same day after market close.
TerrAscend operates in several U.S. states, including Pennsylvania, New Jersey, Maryland, Michigan, and California, and runs retail operations in Canada. The company's portfolio includes brands such as Gage Cannabis, The Apothecarium, Cookies, and more.
TerrAscend announced the outcomes of its annual shareholder meeting held on June 17, 2024. Shareholders approved the election of five directors: Craig Collard, Ira Duarte, Ed Schutter, Kara DioGuardi, and Jason Wild. They also ratified MNP LLP as the independent public accounting firm for the fiscal year ending December 31, 2024. Additionally, shareholders approved amending the expiry dates of stock options for certain employees and directors. The Toronto Stock Exchange (TSX) has neither approved nor disapproved the content of this release, and no securities regulator accepts responsibility for its adequacy or accuracy.
TerrAscend Corp, a major North American cannabis company, has opened The Apothecarium Nottingham, its fourth retail location in Maryland and 39th dispensary nationwide. The new dispensary, located at 8241 Perry Hall Blvd, Nottingham, MD, features a convenient drive-thru and an expanded floor plan. Replacing The Apothecarium Parkville, it serves both patients and adult-use consumers. The location near I-95 and White Marsh Mall offers a wide range of high-quality cannabis products and brands. The grand opening is set for June 13th, with a ribbon-cutting ceremony and various promotions. The company is investing in Maryland's growing market and has recently doubled its cultivation facility's capacity.
TerrAscend has opened its 20th Michigan dispensary, GAGE 313, in Detroit, at 14239 8 Mile Road. This location is TerrAscend’s third in Detroit and aims to provide a top-notch customer experience with a diverse product range, including offerings from brands such as Cookies, GAGE, Kind Tree, Legend, Lemonnade, and local minority-owned brands. Executive Chairman Jason Wild emphasized the company's dedication to Michigan's market, aiming for efficiency and profitability. A grand opening celebration is scheduled for May 31 and June 1, featuring notable attendees and events.
FAQ
What is the current stock price of TERRASCENT (TSNDF)?
What is the market cap of TERRASCENT (TSNDF)?
What markets does TerrAscend operate in?
What are some of TerrAscend's brands?
What type of cannabis products does TerrAscend offer?
What are the core operations of TerrAscend?
How can I contact TerrAscend for more information?
What is the significance of TerrAscend in the cannabis sector?
Does TerrAscend comply with legal regulations in the United States?
Where can I find TerrAscend's retail locations?
What sets TerrAscend apart from other cannabis companies?